Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholestimide for diarrhea in patients with hereditary ATTR amyloidosis
jRCTs031210156Completed
- Start
- Jun 2021
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of cholestyramine in hereditary transthyretin amyloidosis (hATTR) and diarrhea. Primary endpoint: Change in diarrhea frequency. Started Jun 2021; status: completed.
02
Drugs
cholestyramine
03
Conditions
hereditary transthyretin amyloidosis (hATTR)diarrhea
Beyond the preview
Go deeper on jRCTs031210156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210156.